Identifier |
20190318_nanos_sciplatform1_04-abstract |
Title |
Presentation of NAION in a Global Treatment Trial |
Creator |
Mark Kupersmith; Neil Miller; Mays El-Dairi; Leonard Levin; Sharon Klier |
Affiliation |
(MK) Neurology / Ophthalmology, Icahn School of Medicine at Mount Sinai & New York Eye and Ear Infirmary, New York, NY; (NM) Wilmer Institute of Johns Hopkins School of Medicine, Baltimore, MD; (MED) McGill University, QC, Canada; (LL) Duke University, Durham, NC; (SK) Quark Pharmaceutical, CA |
Subject |
Optic Neuropathy; Vascular Disorders; Visual Fields |
Description |
Knowledge of presenting features and systemic factors associated with acute NAION is based predominantly on retrospective reports and one prospective treatment trial, with only 258 participants. The Quark / NORDIC NAION treatment trial will recruit 800 participants and the features of the first 400 enrolled provides the largest prospectively uniformly collected dataset on NAION from multiple sites in 8 countries. |
Date |
2019-04 |
Language |
eng |
Format |
application/pdf |
Type |
Text |
Source |
2019 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS 2018: Scientific Platform I |
Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
Publisher |
North American Neuro-Ophthalmology Society |
Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
Rights Management |
Copyright 2019. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s6fn5mt6 |
Setname |
ehsl_novel_nam |
ID |
1422805 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6fn5mt6 |